Phosphodiesterase type 5 inhibitors and kidney disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-015-1071-4.pdf
Reference58 articles.
1. Bello AK, Levin A, Manns BJ et al (2015) Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis 65:15–25
2. Mortality GBD (2015) Causes of death C: global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171
3. Klahr S, Schreiner G, Ichikawa I (1988) The progression of renal disease. N Engl J Med 318:1657–1666
4. Bae EH, Kim IJ, Joo SY et al (2012) Renoprotective effects of sildenafil in DOCA-salt hypertensive rats. Kidney Blood Press Res 36:248–257
5. Stefoni S, Cianciolo G, Baraldi O et al (2014) Emerging drugs for chronic kidney disease. Expert Opin Emerg Drugs 19:183–199
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials;International Journal of Molecular Sciences;2024-08-30
2. Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension;Diagnostics;2024-08-21
3. Strategies for the enhancement of anti-cancer effect of phosphodiesterase type 5 inhibitors using drug binding fusion proteins;Biotechnology and Bioprocess Engineering;2024-02
4. Exploring the Multifaceted Potential of Sildenafil in Medicine;Medicina;2023-12-17
5. Regulation of renal nitric oxide and eNOS/iNOS expression by tadalafil participates in the mitigation of amphotericin B–induced renal injury: Down-regulation of NF-κB/iNOS/caspase-3 signaling;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3